Identified in at least 35 people in eastern China, a new type of henipavirus, Langya virus, is suspected to have infected shrews before jumping to humans.
This article was first published on ContagionLive.com.
At least 35 patients across 2 Chinese provinces have been infected with the phylogenetically distinct Langya henipavirus (LayV), according to a report in The New England Journal of Medicine.
The investigators reported that they could not find evidence that the virus transmitted between people, suggesting it is spreading zoonotically. Though the sample size is small, they suspect Langya virus was hosted by shrews before infecting humans.
During routine surveillance of fever patients in eastern China with a recent history of animal exposure, a team of investigators isolated acute LayV infection after metagenomic analysis of 1 patient’s throat swab sample.
Subsequently, 35 patients with LayV infection were identified in the Shandong and Henan provinces of China, 26 of whom were infected with LayV alone, meaning no other pathogens were present.
Of these 26 patients, 100% presented with fever, 54% with fatigue, 50% with cough, 50% with anorexia, 46% with myalgia, 38% with nausea, 35% with headache, and 35% with vomiting. Additionally, 35% had abnormalities of thrombocytopenia, 54% leukopenia, 35% impaired liver function, and 8% impaired kidney function. The investigators noted that none of the Langya patients have died of the infection.
A serosurvey of domesticated animals revealed LayV seropositivity in 2% of goats (3 of 168) and 5% of dogs (4 of 79). The investigators also surveyed 25 species of small wild animals, finding LayV RNA in 27% of shrews (71 of 262), suggesting shrews may be a natural reservoir of Langya henipavirus.
The Langya virus is comprised of 18402 nucleotides with genomic organization identical to other henipaviruses. LayV was first detected in 2018 via a sample from a farmer living in the Shandong province who presented with fever. Over the next 2 years, 34 other people, most of them farmers, were infected with the virus in the Shandong and Henan provinces.
Langya henipavirus belongs to the genus henipavirus and family Paramyxoviridae, home to the Hendra and Nipah viruses, which are known to infect and cause fatal disease in humans. LayV is most closely phylogenetically related to Mojiang henipavirus, a virus with a genome length of 18404 nt originally discovered in southern China.
Zoonotic virus spillover is nothing new and not necessarily cause for concern, but the COVID-19 pandemic, which was likely caused by zoonotic viral transfer at a market in Wuhan, China, has escalated the level of concern associated with zoonotic events.
Contact tracing of 9 infected patients with 15 close-contact family members revealed no transmission of LayV. The investigators reiterated the limitations of the small sample size, but hypothesized that unlike COVID-19, human-to-human transfer of Langya henipavirus is fairly unlikely: “There was no close contact or common exposure history among the patients, which suggests that the infection in the human population may be sporadic.”
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies